Chase Sun Pharma's Subsidiary, ChoiceMMed, Explores Strategic Collaboration with

December 15, 2023 — Mr. Lawrence Wang, the General Manager of ChoiceMMed, a subsidiary of Tianjin Chase Sun Pharma, and Dr. Jackie Wang, the General Manager of Australia Chase Sun, jointly visited Omron BD and its sales team in Tokyo, Japan. During the visit, the teams engaged in extensive discussions about the long-term development trends in the medical devices market and strategic plans for collaboration between the two entities.

Following the meeting in Tokyo, the teams further visited Omron's Research and Development Center in Kyoto and the production factory in Hamamatsu, Japan. The accumulated expertise of Omron's Japanese counterparts in blood pressure detection and their dedication to low-carbon, high-efficiency production left a lasting impression on the visiting teams.

Throughout the meeting, the ChoiceMMed team provided a brief overview of the progress in the development of sleeveless blood pressure monitoring devices, which garnered significant interest from the Japanese counterparts. Confidence in the successful market promotion of this product was expressed, and there is anticipation for a deeper collaboration between the ChoiceMMed team and Omron in the future.